@article{8443f12461ad46c9bc2886b254bc3c2b,
title = "Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer",
abstract = "The aim was to evaluate the association between plasma tissue inhibitor of metalloproteinase-1 (TIMP-1) and serum carcinoembryonic antigen (CEA) levels and outcome in patients with metastatic colorectal cancer (mCRC) receiving XELOX (combination chemotherapy with capecitabine and oxaliplatin) as first-line treatment.",
keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Colorectal Neoplasms, Deoxycytidine, Female, Fluorouracil, Humans, Male, Middle Aged, Neoplasm Metastasis, Survival Analysis, Tissue Inhibitor of Metalloproteinase-1, Treatment Outcome",
author = "C Frederiksen and C Qvortrup and Christensen, {I J} and B Glimelius and A Berglund and Jensen, {B V} and Nielsen, {Svend Erik} and N Keldsen and Nielsen, {H J} and Br{\"u}nner, {Nils Aage} and P Pfeiffer",
year = "2011",
doi = "10.1093/annonc/mdq354",
language = "English",
volume = "22",
pages = "369--75",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Elsevier Limited",
number = "2",
}